Overview: Thoracic Outlet
Syndrome Treatment Market
Thoracic outlet
syndrome is the compression of neurovascular structures caused by bodybuilding,
breast tumors, bone abnormalities, trauma, and others. Various factors, such as
the growing number of traffic accidents, anatomical defects, unmet needs in
current treatment, rising research and development costs, and improved
reimbursement policies, spur the growth of the global thoracic outlet syndrome
market.
The global market for thoracic outlet syndrome
is showing significant signs of progress that can take the Thoracic
Outlet Syndrome Treatment Market Application ahead with a 7% CAGR
between 2017 and 2023 that can be considered as the forecast
period for the market. Market Research Future (MRFR) has documented several
changes in the market that can be assessed later for a better understanding of
the strategic moves.
Thoracic Outlet Syndrome is a term that
collectively denotes various heterogeneous and disabling upper-extremity
disorders, which normally happens with the extrinsic compression of the inner
neurovascular structures in between the first rib and the clavicle.
The thoracic outlet syndrome is expecting
significant thrust from rising number of accidents taking place across the
world. Chest injuries where collar bone, ribs, or other bones receive
significant impact may give rise to thoracic outlet syndrome. Various other
anatomical defects can be considered as well to understand the growth for this
market as well. In addition, a lot of injuries often do not get substantial
treatment, better investment in research & development, and policies that
provide better scope for reimbursement can be considered high traction
However, infrastructural deficiency in
underdeveloped countries can hold back the natural growth of the market. Also,
various side-effects that can be associated with the prescribed medicine ca
deter the market growth considerably.
Competitive Landscape: Thoracic
Outlet Syndrome Treatment Market
MRFR
listed some of the major companies in the global market for thoracic outlet syndrome. These companies are
Bayer AG, Abbott
Laboratories, Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo,
Johnson & Johnson Services, Inc., Endo Pharmaceuticals, Inc., Orient Pharma
Co., Ltd., Mallinckrodt plc., Vertical Pharmaceuticals LLC, Sanofi, Par Sterile
Products, LLC., Upsher Smith Laboratories, Inc., SteriMax Inc., and others.
Segmentation: Thoracic
Outlet Syndrome Treatment Market
·
The market for thoracic
outlet syndrome, upon segmentation, reveals treatment, diagnosis, type, and
end-user. MRFR has covered several market possibilities to gain a better view
of the market potentials and various factorial details that can impact the
market growth.
·
By type, the market report on the thoracic outlet syndrome
includes venous thoracic outlet syndrome, neurogenic thoracic outlet syndrome,
and arterial thoracic outlet syndrome.
·
By diagnosis, the market study on the thoracic outlet syndrome
covers vascular studies, nerve conduction studies, cervical spine X-rays, chest
X-ray, magnetic resonance imaging (MRI), computed tomography (CT) scan, and
magnetic resonance imaging is possible with arteriogram/venogram, angiography
(MRA), and blood tests.
·
By treatment, the market report includes physical therapy,
medications, surgery, and others. The medications segment has better market
coverage of muscle relaxant, anticoagulant medications, thrombolytic
medications, and others.
·
By end-user, the market study of thoracic outlet syndrome can be
segmented into diagnostic centers, hospital & clinics, drug pharmacies,
academic & research institutes, and others.
Regional Analysis: Thoracic
Outlet Syndrome Treatment Market
The Americas has the scope to maintain their
dominance over the market in the coming years as several countries from the
region are expected to promote the growth of the market. This is possible due
to people getting aware of the disease and therapeutic process. Also, the
regional expenditure capacity is quite high, especially in countries like the
US and Canada. Other countries like Mexico, Brazil, and Argentina can also
influence better Thoracic Outlet Syndrome Treatment Market growth.
Europe’s strength lies in the support it
receives from its government for research and development programs.
Simultaneously, investments are getting in for innovations, better marketing
strategies, and others. The regional reimbursement policy is also playing a
major part in bringing a lot of companies closer.
The Asia Pacific region can be defined as the
potential fastest growing region. This is mostly getting traction from the huge
patient pool, better inclusion of technologies, possibilities to explore better
expenditure scopes for research & development sector, and others.
The Middle East & Africa (MEA) market can
record a meager growth as the African region may face a slump due to poorly
performing economies.
No comments:
Post a Comment